These Analysts Boost Their Forecasts On Bath & Body Works

Bath & Body Works, Inc. (NYSE:BBWI) affirmed its FY2025 guidance and appointed Daniel Heaf as CEO on Monday.

The company affirmed its adjusted EPS guidance of $3.25 to $3.60 per share versus market estimates of $3.52 per share. The company also affirmed its FY2025 sales outlook of $7.38 billion to $7.53 billion versus expectations of $7.47 billion.

Bath & Body Works shares gained 1.2% to trade at $33.97 on Tuesday.

These analysts made changes to their price targets on Bath & Body Works following the announcement.

  • UBS analyst Jay Sole maintained Bath & Body Works with a Neutral and raised the price target from $32 to $36.
  • Barclays analyst Adrienne Yih maintained the stock with an Equal-Weight rating and raised the price target from $31 to $35.
  • Telsey Advisory Group analyst Dana Telsey maintained Bath & Body Works with an Outperform rating and maintained a $43 price target.

Considering buying BBWI stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.